BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34074810)

  • 21. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases.
    Chen PP; Ramalingam P; Alvarado-Cabrero I; Euscher ED; Nagarajan P; Lawson BC; Malpica A
    Am J Surg Pathol; 2021 Mar; 45(3):304-316. PubMed ID: 32826525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
    Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary large cell neuroendocrine carcinoma of the ureter.
    Oshiro H; Odagaki Y; Iobe H; Ozu C; Takizawa I; Nagai T; Matsubayashi J; Inagaki A; Miyake S; Nagao T
    Int J Clin Exp Pathol; 2013; 6(4):729-36. PubMed ID: 23573321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 29. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
    Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
    Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary cytologic features of primary large cell neuroendocrine carcinoma of the urinary bladder: a case report.
    Oshiro H; Gomi K; Nagahama K; Nagashima Y; Kanazawa M; Kato J; Hatano T; Inayama Y
    Acta Cytol; 2010; 54(3):303-10. PubMed ID: 20518415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas.
    Nakasato T; Hiramatsu A; Matsui Y; Unoki T; Shimoyama H; Oshinomi K; Morita J; Maeda Y; Naoe M; Fuji K; Ogura H; Homma M; Yamochi T; Takimoto M; Ogawa Y
    Cancer Treat Res Commun; 2018; 17():23-30. PubMed ID: 30326420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection.
    Zacharias J; Nicholson AG; Ladas GP; Goldstraw P
    Ann Thorac Surg; 2003 Feb; 75(2):348-52. PubMed ID: 12607637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
    Rossi G; Cavazza A; Marchioni A; Longo L; Migaldi M; Sartori G; Bigiani N; Schirosi L; Casali C; Morandi U; Facciolongo N; Maiorana A; Bavieri M; Fabbri LM; Brambilla E
    J Clin Oncol; 2005 Dec; 23(34):8774-85. PubMed ID: 16314638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
    Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary large-cell neuroendocrine carcinoma of the upper ureter: A case report.
    Choi JH; Sol Y; Lee SW; Jeh SU; Hwa JS; Hyun JS; Chung KH; Seo DH; Yang JW; Song DH; Choi SM
    Medicine (Baltimore); 2019 May; 98(21):e15613. PubMed ID: 31124939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.
    Gupta S; Sahu D; Bomalaski JS; Frank I; Boorjian SA; Thapa P; Cheville JC; Hansel DE
    Endocr Pathol; 2018 Sep; 29(3):236-241. PubMed ID: 29453600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.